First-line Nab-paclitaxel Plus Cisplatin Plus Carilizumab in mTNBC Patients
Condition(s):Breast CancerLast Updated:February 26, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:February 26, 2024Recruiting
Condition(s):Resectable Esophageal Squamous Cell CarcinomaLast Updated:August 23, 2021Unknown status
Condition(s):Diabetes Mellitus, Type 2Last Updated:March 8, 2024Completed
Condition(s):Proximal Gastric Adenocarcinoma; ReconstructionLast Updated:September 14, 2022Recruiting
Condition(s):DLBCL; Lymphoma, B-CellLast Updated:February 9, 2023Recruiting
Condition(s):Rheumatoid ArthritisLast Updated:June 21, 2022Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:July 11, 2023Withdrawn
Condition(s):HealthyLast Updated:May 16, 2013Completed
Condition(s):HER2-negative Breast CancerLast Updated:September 3, 2020Unknown status
Condition(s):Fluid OverloadLast Updated:September 7, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.